Oral Appliance Therapy for Gum Disease
(OAplusPerio Trial)
Trial Summary
Will I have to stop taking my current medications?
No, you will not have to stop taking your current medications. The trial requires participants to continue their current medication and supplement use.
What is the purpose of this trial?
Mouth breathing, snoring and poor sleep can contribute to and worsen periodontitis (gum disease). The purpose of this study is to test whether the myTAP oral appliance with a mouth shield (OA+) can lessen periodontal symptoms in those with these conditions over a 12 week period. In addition to testing sleep respiration and quality, it will also evaluate periodontal pathogens and systemic stress in subjects treated with OA+. This split-mouth clinical trial will include adults with mild to moderate periodontist who snore and mouth breath. All will receive comprehensive periodontal care in addition to OA+ therapy.
Research Team
Emet D Schneiderman, PhD
Principal Investigator
Texas A&M School of Dentistry
Eligibility Criteria
Adults with mild to moderate gum disease who snore and breathe through their mouths during sleep. Participants should not have other health conditions that could affect the trial's results.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Periodontal Treatment
Initial periodontal deep cleaning on one side of the mouth
OA Therapy
Participants use the oral appliance (OA) for 4 weeks
OA+ Therapy
Participants use the oral appliance with mouth shield (OA+) for 8 weeks
Follow-up
Participants are monitored for changes in periodontal conditions and sleep respiration
Treatment Details
Interventions
- MyTAP Oral Appliance Therapy with Mouth Shield
Find a Clinic Near You
Who Is Running the Clinical Trial?
Texas A&M University
Lead Sponsor